BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17931122)

  • 1. Longitudinal neuropsychological assessment in pediatric multiple sclerosis.
    MacAllister WS; Christodoulou C; Milazzo M; Krupp LB
    Dev Neuropsychol; 2007; 32(2):625-44. PubMed ID: 17931122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory decline evolves independently of disease activity in MS.
    Duque B; Sepulcre J; Bejarano B; Samaranch L; Pastor P; Villoslada P
    Mult Scler; 2008 Aug; 14(7):947-53. PubMed ID: 18573817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. May there exist specific MRI findings predictive of dementia in multiple sclerosis patients?
    Patti F; Di Stefano M; De Pascalis D; Ciancio MR; De Bernardis E; Nicoletti F; Reggio A
    Funct Neurol; 1995; 10(2):83-90. PubMed ID: 7557556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes.
    Yeh EA; Parrish JB; Weinstock-Guttman B
    Expert Rev Neurother; 2011 Mar; 11(3):433-40. PubMed ID: 21375448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
    Denney DR; Lynch SG; Parmenter BA
    J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive impairment in the early phase of multiple sclerosis and its relationship with mood, demographic and clinical variables].
    Nieto Barco A; Sánchez López Mdel P; Barroso Ribal J; Olivares Pérez T; Hernández Pérez MA
    Psicothema; 2008 Nov; 20(4):583-8. PubMed ID: 18940054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive functioning in multiple sclerosis.
    Julian LJ
    Neurol Clin; 2011 May; 29(2):507-25. PubMed ID: 21439456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and rehabilitation of cognitive impairment in multiple sclerosis.
    Messinis L; Kosmidis MH; Lyros E; Papathanasopoulos P
    Int Rev Psychiatry; 2010; 22(1):22-34. PubMed ID: 20233112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropsychiatric disorders in multiple sclerosis].
    García-Moreno JM; Duque P; Izquierdo G
    Rev Neurol; 2001 Sep 16-30; 33(6):560-7. PubMed ID: 11727241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis.
    Portaccio E; Goretti B; Lori S; Zipoli V; Centorrino S; Ghezzi A; Patti F; Bianchi V; Comi G; Trojano M; Amato MP;
    Mult Scler; 2009 May; 15(5):620-6. PubMed ID: 19318511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign multiple sclerosis: a new definition of this entity is needed.
    Correale J; Peirano I; Romano L
    Mult Scler; 2012 Feb; 18(2):210-8. PubMed ID: 21865415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.